Danny Nguyen, MD

Danny Nguyen, MD, is a medical oncologist and hematologist at City of Hope National Medical Center in Duarte, California.

Articles by Danny Nguyen, MD

AJMC Q&A with Danny Nguyen, MD | Background image credit: ipopba - stock.adobe.com

Weighing Osimertinib vs Amivantamab-Lazertinib in Frontline EGFR NSCLC: Danny Nguyen, MD

ByLaura Joszt, MA,Danny Nguyen, MD

October 1st 2025

Amivantamab plus lazertinib enhances survival in NSCLC but requires complex care compared with osimertinib, explained Danny Nguyen, MD, of City of Hope.

Impact of Amivantamab-Lazertinib on EGFR, MET Resistance Alterations in NSCLC: Danny Nguyen, MD

ByLaura Joszt, MA,Danny Nguyen, MD

September 15th 2025

The combination of amivantamab and lazertinib in first-line non–small cell lung cancer (NSCLC) significantly reduces resistance mechanisms with implications for second-line treatment, said Danny Nguyen, MD, of City of Hope.

Latest Updated Articles

Weighing Osimertinib vs Amivantamab-Lazertinib in Frontline EGFR NSCLC: Danny Nguyen, MD
Published: October 1st 2025 | Updated:

Danny Nguyen, MD

Articles by Danny Nguyen, MD

Weighing Osimertinib vs Amivantamab-Lazertinib in Frontline EGFR NSCLC: Danny Nguyen, MD

Impact of Amivantamab-Lazertinib on EGFR, MET Resistance Alterations in NSCLC: Danny Nguyen, MD

Latest Updated Articles

Trending on AJMC

Tirzepatide Plus Hormone Therapy Boosts Weight Loss in Menopause: Regina Castaneda, MD

Elinzanetant Shows Consistent Efficacy, Safety, and Sleep Benefits Across Studies

Digital, Blood-Based Innovations Transform Alzheimer Disease Detection: Ken Cohen, MD, FACP

Revumenib Granted FDA Approval for R/R NPM1-Mutated AML

FDA Approves Elinzanetant, a Hormone-Free Option for Hot Flashes in Menopause